Form 4/A for ACIU AC Immune SA
Accepted 2026-04-16 12:39:29 ET · period of report 2026-04-15 · accession 0001651625-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AT | 2026-04-16 12:39 | 2026-04-15 | ACIU | Pfeifer Andrea | CEO, Dir | S - Sale | $3.14 | -10.0K | 3.83M | -0.3% | -$31.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Share | 2026-04-15 | S | D | 10,000 | $3.14 | 3,830,288 | D | — | — | (F1) This Form 4/A amends the Form 4 filed on April 16, 2026, inadvertently reporting in column 3 a purchase of 10,000 shares on behalf of the reporting person. This amendment corrects that filing to reflect that the reporting person sold 10,000 shares. (F2) The price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.05 to $3.19, inclusive. (F3) Includes 1,921,005 common shares underlying outstanding restricted share units. |